Mix it fix-it: Moderna aims for range of vaccine dose levels to fight variants, jab kids

The drugmaker hopes to have the products on the market by 2022, when it aims to deliver up to three billion doses

02 June 2021 - 20:23 By John Miller

Moderna is gearing up to halve the dose of its Covid-19 vaccine, the US drugmaker said on Wednesday. This to combat variants and inoculate children.

It has agreed a deal with Swiss-based drugmaker Lonza, which said a new drug substance production line in Geleen, Netherlands, will have capacity to make ingredients for up to 300 million doses annually at 50 micrograms per dose...

This article is free to read if you register or sign in.

If you have already registered or subscribed, please sign in to continue.

Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.